首页 | 本学科首页   官方微博 | 高级检索  
     

瑞格列奈联合阿卡波糖治疗2型糖尿病的临床效果及HbA1c、FPG、2hPG水平影响评价
引用本文:孙光. 瑞格列奈联合阿卡波糖治疗2型糖尿病的临床效果及HbA1c、FPG、2hPG水平影响评价[J]. 糖尿病新世界, 2021, 0(4): 101-103
作者姓名:孙光
作者单位:淄博市第六人民医院药械科
摘    要:目的 分析瑞格列奈联合阿卡波糖治疗2型糖尿病的临床效果及对HbA1c、FPG、2 hPG水平的影响.方法 该次研究中的88例观察对象均抽选于2019年4月—2020年4月在该院接受治疗的2型糖尿病患者当中.应用数字随机分组的方式将患者分为两组,对照组患者接受瑞格列奈联合盐酸二甲双胍治疗,观察组患者给予瑞格列奈联合阿卡波...

关 键 词:瑞格列奈  阿卡波糖  2型糖尿病  临床效果  HbA1c  FPG  2hPG

The Clinical Effect of Repaglinide Combined with Acarbose in the Treatment of Type 2 Diabetes and the Impact Evaluation of HbAlc,FPG and 2 hPG Levels
SUN Guang. The Clinical Effect of Repaglinide Combined with Acarbose in the Treatment of Type 2 Diabetes and the Impact Evaluation of HbAlc,FPG and 2 hPG Levels[J]. Diabetes New World, 2021, 0(4): 101-103
Authors:SUN Guang
Affiliation:(Department of Medicine and Equipment,the Sixth People's Hospital of Zibo,Zibo,Shandong Province,255000 China)
Abstract:Objective To analyze the clinical effect of repaglinide combined with acarbose in the treatment of type 2 diabetes and its influence on the levels of HbA1c,FPG and 2 hPG.Methods The observation subjects in this study were selected from patients with type 2 diabetes who were treated in the hospital,from April 2019 to April 2020.The patients were divided into two groups by numerical randomization.The control group received repaglinide combined with metformin hydrochloride treatment,and the observation group received repaglinide combined with acarbose.Both groups received three months of treatment for medication,compared the improvement of blood glucose level,clinical efficacy and occurrence of adverse reactions.Results Before treatment,compared with the fasting blood glucose(FPG),2 h postprandial blood glucose(2 hPG)and glycosylated hemoglobin(HbA1c)levels of the observation group and the control group,and the difference was not statistically significant(P>0.05).After treatment,the fasting blood glucose and postprandial blood glucose,2 h blood glucose and glycosylated hemoglobin of the observation group were significantly lower than before treatment and the control group,and the difference was statistically significant(P<0.05);the total clinical improvement rate of the observation group was significantly higher than that of the control group,and the difference was statistically significant(P<0.05);the incidence of adverse reactions in the observation group was similar to that of the control group,and the difference was not statistically significant(P>0.05).Conclusion Repaglinide combined with acarbose has a significant clinical effect in the treatment of type 2 diabetes.It can effectively control the blood glucose level of patients with high safety.
Keywords:Repaglinide  Acarbose  Type 2 diabetes  Clinical effects  HbA1c  FPG  2 hPG
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号